Polydeoxyribonucleotide (PDRN) Selectively Promotes Osteoblast Differentiation Without Affecting Osteoclastogenesis

Developing novel anabolic agents for bone regeneration remains a clinical priority. Polydeoxyribonucleotide (PDRN) exhibits tissue-regenerative properties, but its direct cellular effects on bone remodeling remain unclear. This in vitro study investigated PDRN’s effects on osteoblast (MC3T3-E1) and...

Полное описание

Библиографические подробности

Главные авторы:	Younghoon Jeon, Eunjung Heo, Xian Jin, Dong-Kyo Lee, Xiangguo Che, Hyun-Ju Kim, Sung-Hye Byun, Je-Yong Choi, Jeongkyu Choi, Jinyoung Oh
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2026-03-01
Серии:	Marine Drugs
Предметы:	polydeoxyribonucleotide osteoblast differentiation adenosine A<sub>2A</sub> receptor bone regeneration osteoclast
Online-ссылка:	https://www.mdpi.com/1660-3397/24/3/100
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!